CEO Peter Stern is targeting Peloton GLP-1 drug users and expanding the treadmill lineup as part of a broader strategy to grow the company's customer base and revenue.
CEO Peter Stern is targeting Peloton GLP-1 drug users and expanding the treadmill lineup as part of a broader strategy to grow the company's customer base and revenue.